WANY
Wealthspire Advisors (New York)’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.8K | Buy |
13,993
+1,508
| +12% | +$7.63K | ﹤0.01% | 831 |
|
|
2025
Q1 | $66K | Hold |
12,485
| – | – | ﹤0.01% | 771 |
|
|
2024
Q4 | $84.4K | Buy |
12,485
+1,158
| +10% | +$7.83K | ﹤0.01% | 772 |
|
|
2024
Q3 | $74.6K | Sell |
11,327
-1,000
| -8% | -$6.59K | ﹤0.01% | 732 |
|
|
2024
Q2 | $92.5K | Buy |
12,327
+1,000
| +9% | +$7.5K | ﹤0.01% | 642 |
|
|
2024
Q1 | $113K | Hold |
11,327
| – | – | ﹤0.01% | 624 |
|
|
2023
Q4 | $112K | Hold |
11,327
| – | – | ﹤0.01% | 631 |
|
|
2023
Q3 | $86.7K | Buy |
+11,327
| New | +$86.7K | ﹤0.01% | 582 |
|